Kolexia
Harroche-Angel Annie Pédiatrie
Harroche-Angel Annie
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
131 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Maladies de von Willebrand Thrombose Maladies articulaires Urgences Thrombose veineuse Hémophilie B Troubles congénitaux de la glycosylation

Collaborateurs

Voir plus
Trossaert Marc
Trossaert Marc
Hôpital Hôtel-Dieu Nantes, Nantes, France
D'Oiron Roseline
D'Oiron Roseline
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Repesse Yohann
Repesse Yohann
Hôpital Côte de Nacre, Caen, France
Chambost Herve
Chambost Herve
Hôpital La Timone Enfants, Marseille, France

Industries

Voir plus
Roche
39 collaboration(s)
Dernière en 2023
Sobi
33 collaboration(s)
Dernière en 2023
CSL Behring
18 collaboration(s)
Dernière en 2021
LFB
16 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Emicizumab and asparaginase, A first experience to share.
Haemophilia : the official journal of the World Federation of Hemophilia   19 janvier 2024
Pediatric intracranial empyema complicating otogenic and sinogenic infection.
International journal of pediatric otorhinolaryngology   11 janvier 2024
Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases.
British journal of haematology   08 janvier 2024
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.
Haemophilia : the official journal of the World Federation of Hemophilia   25 décembre 2023
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD): A Phase 3b, Prospective, Open-Label, Uncontrolled, Multicenter Study on Long-Term Safety and Efficacy of rVWF in Pediatric and Adult Subjects With Severe Von Willebrand Disease (VWD)
Essai Clinique (Shire)   14 novembre 2023
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD): A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
Essai Clinique (Shire)   09 novembre 2023
Interferences by factor VIII and lupus anticoagulant in the modified one-stage assay for emicizumab.
Haemophilia : the official journal of the World Federation of Hemophilia   25 septembre 2023
French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
La Revue de medecine interne   19 septembre 2023
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): A multicentric French national observational cross-sectional study based on the FranceCoag registry.
Haemophilia : the official journal of the World Federation of Hemophilia   12 août 2023
Thromboses veineuses sur cathéter central chez l’enfant : recommandations du groupe des pédiatres de la Société française de thrombose et d’hémostase (SFTH)
Perfectionnement en Pédiatrie   09 août 2023